A Paradigm Shift in Pharmacokinetic–Pharmacodynamic (PKPD) Modeling: Rule of Thumb for Estimating Free Drug Level in Tissue Compared with Plasma to Guide Drug Design

2015 ◽  
Vol 104 (7) ◽  
pp. 2359-2368 ◽  
Author(s):  
Patrick Poulin
Author(s):  
Donald F. Weaver

ABSTRACT:There is still no medical cure for epilepsy. Clinical epileptology is in need of a “paradigm shift” when it comes to the continuing development of therapeutics. An important first step in this conceptual evolution is differentiating between the notions of ictogenesis and epileptogenesis. All traditional therapeutics are anti-ictogenic, not antiepileptogenic. The future of antiepileptic drug development lies in the discovery of antiepileptogenics. Just as aspirin is not the drug of choice for meningitis, an anticonvulsant is not the drug of choice for epilepsy. Drug design for epilepsy needs to discover a penicillin, not more aspirins.


2008 ◽  
Vol 4 (2) ◽  
pp. 76-90 ◽  
Author(s):  
Nigus Dessalew ◽  
Workalemahu Mikre
Keyword(s):  

1984 ◽  
Vol 6 (1) ◽  
pp. 67-76 ◽  
Author(s):  
R H. Levy ◽  
P. N. Friel ◽  
L. M. Linthicum ◽  
L. Colin ◽  
K. Koch ◽  
...  

1984 ◽  
Vol 9 (Supplement 1) ◽  
pp. 79-83 ◽  
Author(s):  
Raymond L. Woosley ◽  
Lyle A. Siddoway ◽  
Katherine Thompson ◽  
Irene Cerskus ◽  
Dan M. Roden

1985 ◽  
Vol 30 (1) ◽  
pp. 17-17
Author(s):  
Marion Perlmutter
Keyword(s):  

1994 ◽  
Vol 39 (2) ◽  
pp. 197-198
Author(s):  
Raymond T. Garza
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document